Literature DB >> 19655167

Genetic variants A1826H and D2937Y in GAG-beta domain of versican influence susceptibility to intestinal-type gastric cancer.

Hyoungseok Ju1, Byungho Lim, Minjin Kim, Seung-Moo Noh, Dong Soo Han, Hang-Jong Yu, Bo Youl Choi, Yong Sung Kim, Woo Ho Kim, Chunhwa Ihm, Changwon Kang.   

Abstract

PURPOSE: Versican regulates adhesion, migration, proliferation, and survival of cells, and plays an important role in cancer development. A case-control association study was performed to test genetic association of versican polymorphisms with susceptibility to gastric cancer.
METHODS: In this study, 1,101 unrelated Korean subjects including 612 gastric cancer patients and 489 healthy controls were genotyped for all 21 exonic polymorphisms in the versican gene (VCAN) encoding amino acid changes in versican. Cancer susceptibility associations with the polymorphisms were assessed using multivariate logistic regression analysis with adjustment for age and gender and with control for multiple testing.
RESULTS: Two amino acid changes in GAG-beta domain of versican encoded by two almost fully correlated (r (2) = 0.97) nonsynonymous single-nucleotide polymorphisms in VCAN were associated with gastric cancer. The association was evident in intestinal-type but not in diffuse-type gastric cancer. The minor-allele homozygote of rs188703 (G > A, R1826H) or rs160277 (G > T, D2937Y) was significantly associated with a twofold decreased susceptibility to intestinal-type gastric cancer when compared with the other genotypes (adjusted odds ratio = 0.52 or 0.51, P = 0.0098 or 0.0087, respectively).
CONCLUSIONS: The intestinal-type gastric cancer susceptibility is associated with two amino acid changes of versican in the GAG-beta domain, which is critical for enhancement of cell proliferation and activation of EGFR signal pathway by versican, and changes from the major to minor alleles may impair the function to decrease susceptibility to cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655167     DOI: 10.1007/s00432-009-0647-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

1.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

2.  The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells.

Authors:  Sabrina Cattaruzza; Monica Schiappacassi; Koji Kimata; Alfonso Colombatti; Roberto Perris
Journal:  FASEB J       Date:  2004-02-20       Impact factor: 5.191

3.  Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.

Authors:  L F Brown; A J Guidi; S J Schnitt; L Van De Water; M L Iruela-Arispe; T K Yeo; K Tognazzi; H F Dvorak
Journal:  Clin Cancer Res       Date:  1999-05       Impact factor: 12.531

Review 4.  Versican: a versatile extracellular matrix proteoglycan in cell biology.

Authors:  Thomas N Wight
Journal:  Curr Opin Cell Biol       Date:  2002-10       Impact factor: 8.382

5.  Versican protects cells from oxidative stress-induced apoptosis.

Authors:  Yaojiong Wu; Jin Wu; Daniel Y Lee; Albert Yee; Liu Cao; Yaou Zhang; Chris Kiani; Burton B Yang
Journal:  Matrix Biol       Date:  2005-02       Impact factor: 11.583

6.  Versican in health and disease.

Authors:  Achilleas D Theocharis
Journal:  Connect Tissue Res       Date:  2008       Impact factor: 3.417

7.  Human non-synonymous SNPs: server and survey.

Authors:  Vasily Ramensky; Peer Bork; Shamil Sunyaev
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

8.  Differential expression of versican isoforms in brain tumors.

Authors:  W Paulus; I Baur; M T Dours-Zimmermann; D R Zimmermann
Journal:  J Neuropathol Exp Neurol       Date:  1996-05       Impact factor: 3.685

9.  Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer.

Authors:  Alex Boussioutas; Hong Li; Jia Liu; Paul Waring; Stephen Lade; Andrew J Holloway; Douglas Taupin; Kylie Gorringe; Izhak Haviv; Paul V Desmond; David D L Bowtell
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

10.  The ability of versican to simultaneously cause apoptotic resistance and sensitivity.

Authors:  David P LaPierre; Daniel Y Lee; Sen-Zhu Li; Yi-Zhen Xie; Ling Zhong; Wang Sheng; Zhaoqun Deng; Burton B Yang
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

View more
  6 in total

1.  Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican.

Authors:  Zhenwei Zhang; Jianpeng Zhang; Lei Miao; Ke Liu; Shengsheng Yang; Chuanyong Pan; Binghua Jiao
Journal:  Int J Biol Sci       Date:  2012-02-23       Impact factor: 6.580

2.  Association of Versican (VCAN) gene polymorphisms rs251124 and rs2287926 (G428D), with intracranial aneurysm.

Authors:  Sanish Sathyan; Linda V Koshy; Shabeesh Balan; H V Easwer; S Premkumar; Suresh Nair; R N Bhattacharya; Jacob P Alapatt; Moinak Banerjee
Journal:  Meta Gene       Date:  2014-09-14

3.  Prognostic significance of Versican expression in gastric adenocarcinoma.

Authors:  X-H Shen; W-R Lin; M-D Xu; P Qi; L Dong; Q-Y Zhang; S-J Ni; W-W Weng; C Tan; D Huang; Y-Q Ma; W Zhang; W-Q Sheng; Y-Q Wang; X Du
Journal:  Oncogenesis       Date:  2015-11-30       Impact factor: 7.485

4.  DBGC: A Database of Human Gastric Cancer.

Authors:  Chao Wang; Jun Zhang; Mingdeng Cai; Zhenggang Zhu; Wenjie Gu; Yingyan Yu; Xiaoyan Zhang
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

5.  Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Xiaoguang Liu; Chuangye Han; Xiwen Liao; Long Yu; Guangzhi Zhu; Hao Su; Wei Qin; Sicong Lu; Xinping Ye; Tao Peng
Journal:  Cancer Manag Res       Date:  2018-05-04       Impact factor: 3.989

6.  SCDb: an integrated database of stomach cancer.

Authors:  Erli Gu; Wei Song; Ajing Liu; Hong Wang
Journal:  BMC Cancer       Date:  2020-06-02       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.